You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NTRK2

Showing 26 - 50 of 84
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Larotrectinib Sulfate
  • Houston, Texas
    M D Anderson Cancer Center
Apr 18, 2022

Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • +3 more
  • Larotrectinib monotherapy
  • 131I therapy
  • (no location specified)
Mar 13, 2023

Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Providence (TY-2136b)

Not yet recruiting
  • Locally Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Providence, Rhode Island
    Rhode Island Hospital, Brown University
Mar 2, 2023

Cervical/Supraclavicular Metastasis From Non-small-cell Lung

Recruiting
  • Lung Cancer Metastatic
  • Needle or forceps biopsy of cervical and/or supraclavicular lymph nodes
  • Needle, forceps or surgical biopsy of any lesion other than cervical and/or supraclavicular lymph nodes
  • Roma, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Worldwide (Larotrectinib, Larotrectinib surgical)

Recruiting
  • High Grade Glioma
  • Diffuse Intrinsic Pontine Glioma
  • Aurora, Colorado
  • +17 more
Aug 10, 2022

NSCLC Trial in United States (Alectinib, Entrectinib, Vemurafenib)

Recruiting
  • Non-small Cell Lung Cancer
  • Duarte, California
  • +24 more
Feb 2, 2023

NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

Not yet recruiting
  • NSCLC Stage IV
  • +4 more
  • Nivolumab and Ipilimumab
  • Verona, Veneto/Verona, Italy
    Centro Ricerche Cliniche
Oct 26, 2022

Cancers With NTRK, ROS1, or ALK Gene Fusions Trial in San Diego (Entrectinib)

No longer available
  • Cancers With NTRK, ROS1, or ALK Gene Fusions
  • San Diego, California
    1-844-Startrk (782-7875)
Apr 24, 2019

Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +30 more
  • Larotrectinib Sulfate
  • Birmingham, Alabama
  • +123 more
Aug 23, 2022

Thyroid Carcinoma

Recruiting
  • Differentiated Thyroid Carcinoma
  • Medullary Thyroid Carcinoma
  • Immunohistochemistry (IHC)
  • +2 more
  • L'Hospitalet De Llobregat, Barcelona, Spain
  • +11 more
Mar 22, 2022

Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Trial in Shanghai (SIM1803-1A)

Recruiting
  • Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion
  • Shanghai, China
    Shanghai Chest Hospital
Jan 11, 2021

Post Traumatic Stress Disorder, Complex PTSD, Stress Trial in Palo Alto, San Juan (Start with the Heart Students, Start with the

Not yet recruiting
  • Post Traumatic Stress Disorder
  • +4 more
  • Start with the Heart Students
  • +4 more
  • Palo Alto, California
  • +1 more
Jan 24, 2023

Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic NSCLC Trial in Beijing (XZP-5955 tablets)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • Locally Advanced or Metastatic Non-small Cell Lung Cancer
  • XZP-5955 tablets
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
May 17, 2022

China With Non-Small-Cell Lung Cancer That is Unable to be

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    May 16, 2023

    NTRK Gene Fusion in Adult Brain Tumours

    Not yet recruiting
    • Glioma
    • Glioma data collection
    • Brain metastasis data collection
    • Marseille, France
      Hôpital Privé Clairval
    Aug 24, 2021

    Lung Cancer Trial in Angers, St Herblain (Metastasis biopsy)

    Not yet recruiting
    • Lung Cancer
    • Metastasis biopsy
    • Angers, France
    • +1 more
    Jul 26, 2022

    Advanced Solid Tumor Trial in Changsha (IBI363)

    Not yet recruiting
    • Advanced Solid Tumor
    • Changsha, Hunan, China
      Yongchang Zhang
    Oct 12, 2023

    Resistance-associated Mutations in Metastatic Lung Cancer

    Recruiting
    • Lung Cancer
    • Liquid biopsy
    • Monza, MB, Italy
      Fondazione IRCCS San Gerardo dei Tintori
    Oct 10, 2023

    Advanced Solid Malignant Tumors Trial in Fukuoka, Osaka, Tokyo (DS-6051b)

    Active, not recruiting
    • Advanced Solid Malignant Tumors
    • Fukuoka, Japan
    • +2 more
    Jan 18, 2022

    Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Decitabine and Cedazuridine
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    May 25, 2022

    Advanced Solid Tumor Trial in Shanghai (FCN-011)

    Recruiting
    • Advanced Solid Tumor
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 16, 2021

    LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic

    Recruiting
    • Non Small Cell Lung Cancer
      • Los Angeles, California
      • +5 more
      Jun 9, 2022

      Metastasis, Tumor Trial in HangZhou (BPI-28592)

      Recruiting
      • Metastasis, Neoplasm
      • HangZhou, Zhejiang, China
        Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
      Mar 21, 2022

      Solid Tumors Trial in United States (DS6051b)

      Completed
      • Solid Tumors
      • Scottsdale, Arizona
      • +5 more
      Sep 18, 2020

      Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

      Recruiting
      • Lymphoma, Non-Hodgkin
      • +2 more
      • Edmonton, Alberta, Canada
      • +9 more
      Jan 9, 2023